Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on ...

ZHENJIANG, China, Dec. 7, 2021 /PRNewswire/ -- On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off. GenScript ProBio ...

PISCATAWAY, N.J., Dec. 4, 2024 /PRNewswire/ -- GenScript Biotech, a global biotechnology leader in the life science, biologics manufacturing, synthetic biology, and cell therapies announced today that ...

Latest innovative laboratory automation technology from GenScript is set to streamline maxi-scale plasmid purification, significantly reducing the manpower and time required to obtain high-quality, ...

NANJING, China, Jan. 15, 2020 /PRNewswire/ -- On January 14, 2020, at San Francisco, USA, a global leading biotech company GenScript announced that it signed a strategic partnership agreement for the ...

PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a ...

Chinese CDMO GenScript Biotech already has a deal to produce a CAR-T drug being developed by its Legend Biotech unit and Janssen. But the contract manufacturer has started construction on a production ...

DUBLIN--(BUSINESS WIRE)--The "Viral Vector and Plasmid DNA: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive summary of ...

Bringing a new drug to the market is capital and labour intensive. To achieve cost-effectiveness and meet strict compliance standards, many drug developers choose to focus on in-house research and ...

Cell and gene therapies are redefining the treatments of rare diseases and cancers. Two CAR-T therapies, for instance, rapidly achieved FDA approval in the US and have emerged recently as the new ...